Retour

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

Calendar Calendar of Events

ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 9:30 a.m. ET in New York, NY.

GlobeNewswire Inc. • 08/05/2024 à 22:15:00
Clearside Biomedical, Inc. Common Stock
Address: 900 NORTH POINT PARKWAY
Postal Code: 30005
City: ALPHARETTA
State: GA
Phone Number: 678-270-3631
Website: https://www.clearsidebio.com
Status: Active
Company Info

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

List Date2016-06-02
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001539029
Composite figiBBG002D4D4X3
Share Class figiBBG002D4D4Z1
Market Cap97,897,792 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees30
Share Class Shares Outstanding74730000
Weighted Shares Outstanding74731139
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
1.33
1.315
1.334
1.28
1.244
Variance
1.53%
-1.5%
4.22%
2.81%
-1.43%
Open
1.31
1.335
1.28
1.245
1.262
Highest
1.34
1.34
1.34
1.28
1.28
Lowest
1.34
1.335
1.34
1.275
1.28
History
PeriodVarhighestlowest
1 week
5.39%
1.28
1.275
1 month
2.94%
1.445
1.275
3 month
-68.43%
4.213
1.265
6 month
37.11%
0.9917
0.9243
1 year
31.68%
1.04
0.650101
3 year
-43.64%
2.5651
0.650101
5 year
7.26%
1.24
0.56
10 year
-83.38%
8.45
0.56
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-14 2023-11-13 UNPUB
Assets 44,695,000 39,185,000 34,420,000 UNPUB
Current Assets 42,567,000 36,107,000 30,815,000 UNPUB
Current Liabilities 4,984,000 5,274,000 5,835,000 UNPUB
Equity 2,700,000 -4,973,000 -12,849,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 2,700,000 -4,973,000 -12,849,000 UNPUB
Liabilities 41,995,000 44,158,000 47,269,000 UNPUB
Liabilities And Equity 44,695,000 39,185,000 34,420,000 UNPUB
Noncurrent Assets 2,128,000 3,078,000 3,605,000 UNPUB
Noncurrent Liabilities 37,011,000 38,884,000 41,434,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-14 2023-11-13 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -6,999,000 -6,414,000 -6,203,000 UNPUB
Net Cash Flow, Continuing -6,999,000 -6,414,000 -6,203,000 UNPUB
Net Cash Flow From Financing Activities 332,000 22,000 317,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 332,000 22,000 317,000 UNPUB
Net Cash Flow From Investing Activities -115,000 -1,097,000 -445,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -115,000 -1,097,000 -445,000 UNPUB
Net Cash Flow From Operating Activities -7,216,000 -5,339,000 -6,075,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -7,216,000 -5,339,000 -6,075,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-14 2023-11-13 UNPUB
Comprehensive Income/Loss -9,280,000 -9,106,000 -9,267,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -9,280,000 -9,106,000 -9,267,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-12 2023-08-14 2023-11-13 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 9,284,000 0 0 UNPUB
Cost Of Revenue UNPUB 213,000 142,000 UNPUB
Costs And Expenses 9,284,000 8,288,000 7,913,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit UNPUB 805,000 717,000 UNPUB
Income/Loss From Continuing Operations After Tax -9,280,000 -9,106,000 -9,267,000 UNPUB
Income/Loss From Continuing Operations Before Tax -9,280,000 1,018,000 859,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -9,280,000 -9,106,000 -9,267,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -9,280,000 -9,106,000 -9,267,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -9,280,000 -9,106,000 -9,267,000 UNPUB
Operating Expenses 7,609,000 8,288,000 7,913,000 UNPUB
Operating Income/Loss -7,605,000 -7,270,000 -7,054,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 4,000 1,018,000 859,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-09 2023-03-14
Assets 36,059,000 30,746,000 55,685,000 51,303,000
Current Assets 35,274,000 29,989,000 54,862,000 49,401,000
Current Liabilities 4,156,000 5,393,000 5,204,000 5,783,000
Equity 31,703,000 25,248,000 18,546,000 10,607,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 31,703,000 25,248,000 18,546,000 10,607,000
Liabilities 4,356,000 5,498,000 37,139,000 40,696,000
Liabilities And Equity 36,059,000 30,746,000 55,685,000 51,303,000
Noncurrent Assets 785,000 757,000 823,000 1,902,000
Noncurrent Liabilities 0 0 31,935,000 34,913,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-09 2023-03-14
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 17,722,000
Net Cash Flow, Continuing 0 0 0 17,722,000
Net Cash Flow From Financing Activities 65,000 4,000 30,689,000 31,333,000
Net Cash Flow From Financing Activities, Continuing 65,000 4,000 30,689,000 31,333,000
Net Cash Flow From Investing Activities -3,936,000 5,439,000 -24,503,000 -246,000
Net Cash Flow From Investing Activities, Continuing -3,936,000 5,439,000 -24,503,000 -246,000
Net Cash Flow From Operating Activities 3,871,000 -5,443,000 -6,186,000 -13,365,000
Net Cash Flow From Operating Activities, Continuing 3,871,000 -5,443,000 -6,186,000 -13,365,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-09 2023-03-14
Comprehensive Income/Loss -7,644,000 -7,813,000 -7,827,000 -32,947,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,644,000 -7,813,000 -7,827,000 -32,947,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-12 2022-11-09 2023-03-14
Basic Earnings Per Share UNPUB UNPUB 0 -1
Benefits Costs and Expenses 7,991,000 0 0 34,274,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 7,991,000 8,221,000 6,990,000 34,274,000
Diluted Earnings Per Share UNPUB UNPUB 0 -1
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -7,644,000 -7,813,000 -7,827,000 -32,947,000
Income/Loss From Continuing Operations Before Tax -7,644,000 -7,813,000 266,000 -32,947,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -7,644,000 -7,813,000 -7,827,000 -32,947,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -7,644,000 -7,813,000 -7,827,000 -32,947,000
Net Income/Loss Available To Common Stockholders, Basic -7,644,000 -7,813,000 -7,827,000 -32,947,000
Operating Expenses 7,993,000 8,221,000 6,990,000 31,604,000
Operating Income/Loss -7,646,000 -7,837,000 -6,724,000 -30,277,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 347,000 384,000 266,000 1,327,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-10 2022-03-11
Assets 27,821,000 28,592,000 27,378,000 42,903,000
Current Assets 26,699,000 27,653,000 26,523,000 42,136,000
Current Liabilities 10,297,000 8,796,000 9,156,000 4,640,000
Equity 16,985,000 19,338,000 17,848,000 37,975,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 16,985,000 19,338,000 17,848,000 37,975,000
Liabilities 10,836,000 9,254,000 9,530,000 4,928,000
Liabilities And Equity 27,821,000 28,592,000 27,378,000 42,903,000
Noncurrent Assets 1,122,000 939,000 855,000 767,000
Noncurrent Liabilities 0 0 374,000 288,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-10 2022-03-11
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 0
Net Cash Flow, Continuing 0 0 0 0
Net Cash Flow From Financing Activities 14,419,000 7,117,000 2,081,000 23,782,000
Net Cash Flow From Financing Activities, Continuing 14,419,000 7,117,000 2,081,000 23,782,000
Net Cash Flow From Investing Activities -8,860,000 -167,000 1,197,000 -13,049,000
Net Cash Flow From Investing Activities, Continuing -8,860,000 -167,000 1,197,000 -13,049,000
Net Cash Flow From Operating Activities -5,559,000 -6,950,000 -3,278,000 -10,733,000
Net Cash Flow From Operating Activities, Continuing -5,559,000 -6,950,000 -3,278,000 -10,733,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-10 2022-03-11
Comprehensive Income/Loss -7,351,000 -6,095,000 -4,887,000 -376,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,351,000 -6,095,000 -4,887,000 -376,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-10 2022-03-11
Basic Earnings Per Share UNPUB UNPUB UNPUB 0
Benefits Costs and Expenses 7,385,000 0 0 29,951,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 7,385,000 6,876,000 7,963,000 29,951,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB 0
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -7,351,000 -6,095,000 -4,887,000 -376,000
Income/Loss From Continuing Operations Before Tax -7,351,000 -6,095,000 3,074,000 -376,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -7,351,000 -6,095,000 -4,887,000 -376,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 -752,000
Net Income/Loss Attributable To Parent -7,351,000 -6,095,000 -4,887,000 376,000
Net Income/Loss Available To Common Stockholders, Basic -7,351,000 -6,095,000 -4,887,000 376,000
Operating Expenses 8,383,000 6,876,000 7,963,000 30,202,000
Operating Income/Loss -8,349,000 -6,096,000 -4,889,000 -627,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 34,000 780,000 3,074,000 29,575,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-10 2021-03-15
Assets 25,043,000 17,738,000 17,405,000 19,322,000
Current Assets 23,505,000 16,277,000 16,022,000 18,118,000
Current Liabilities 13,771,000 9,193,000 8,207,000 9,943,000
Equity 10,440,000 7,287,000 8,124,000 8,763,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 10,440,000 7,287,000 8,124,000 8,763,000
Liabilities 14,603,000 10,451,000 9,281,000 10,559,000
Liabilities And Equity 25,043,000 17,738,000 17,405,000 19,322,000
Noncurrent Assets 1,538,000 1,461,000 1,383,000 1,204,000
Noncurrent Liabilities 0 0 1,074,000 616,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-10 2021-03-15
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -1,665,000 -5,859,000 -232,000 -5,308,000
Net Cash Flow, Continuing -1,665,000 -5,859,000 -232,000 -5,308,000
Net Cash Flow From Financing Activities 1,193,000 -2,639,000 2,429,000 7,867,000
Net Cash Flow From Financing Activities, Continuing 1,193,000 -2,639,000 2,429,000 7,867,000
Net Cash Flow From Investing Activities -55,000 0 0 -55,000
Net Cash Flow From Investing Activities, Continuing -55,000 0 0 -55,000
Net Cash Flow From Operating Activities -2,803,000 -3,220,000 -2,661,000 -13,120,000
Net Cash Flow From Operating Activities, Continuing -2,803,000 -3,220,000 -2,661,000 -13,120,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-10 2021-03-15
Comprehensive Income/Loss -2,911,000 -5,754,000 -2,433,000 -18,210,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,911,000 -5,754,000 -2,433,000 -18,210,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-10 2021-03-15
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 7,008,000 0 0 26,104,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 7,008,000 5,911,000 5,864,000 26,104,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,911,000 -5,754,000 -2,433,000 -18,210,000
Income/Loss From Continuing Operations Before Tax -2,911,000 -5,754,000 3,432,000 -18,210,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 106,000 42,000 0 147,000
Net Income/Loss -2,911,000 -5,754,000 -2,433,000 -18,210,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,911,000 -5,754,000 -2,433,000 -18,210,000
Net Income/Loss Available To Common Stockholders, Basic -2,911,000 -5,754,000 -2,433,000 -18,210,000
Operating Expenses 6,933,000 5,911,000 5,864,000 25,829,000
Operating Income/Loss -2,836,000 -5,557,000 -2,432,000 -17,935,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 4,097,000 354,000 3,432,000 7,894,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-08 2019-11-08 2020-03-13
Assets 37,534,000 29,854,000 25,867,000 26,776,000
Current Assets 35,468,000 27,893,000 24,046,000 25,219,000
Current Liabilities 11,666,000 8,041,000 10,818,000 10,903,000
Equity 16,091,000 12,901,000 9,759,000 11,157,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 16,091,000 12,901,000 9,759,000 11,157,000
Liabilities 21,443,000 16,953,000 16,108,000 15,619,000
Liabilities And Equity 37,534,000 29,854,000 25,867,000 26,776,000
Noncurrent Assets 2,066,000 1,961,000 1,821,000 1,557,000
Noncurrent Liabilities 0 0 5,290,000 4,716,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-08 2019-11-08 2020-03-13
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 24,907,000 -6,776,000 -3,623,000 14,552,000
Net Cash Flow, Continuing 24,907,000 -6,776,000 -3,623,000 14,552,000
Net Cash Flow From Financing Activities 6,628,000 1,288,000 2,424,000 8,695,000
Net Cash Flow From Financing Activities, Continuing 6,628,000 1,288,000 2,424,000 8,695,000
Net Cash Flow From Investing Activities 30,932,000 1,993,000 0 32,925,000
Net Cash Flow From Investing Activities, Continuing 30,932,000 1,993,000 0 32,925,000
Net Cash Flow From Operating Activities -12,653,000 -10,057,000 -6,047,000 -27,068,000
Net Cash Flow From Operating Activities, Continuing -12,653,000 -10,057,000 -6,047,000 -27,068,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-08 2019-11-08 2020-03-13
Comprehensive Income/Loss -15,404,000 -5,734,000 -6,536,000 -30,770,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -15,404,000 -5,734,000 -6,536,000 -30,770,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-10 2019-08-08 2019-11-08 2020-03-13
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 15,449,000 0 0 32,943,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 15,449,000 5,662,000 6,509,000 32,943,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -15,404,000 -5,734,000 -6,536,000 -30,770,000
Income/Loss From Continuing Operations Before Tax -15,404,000 -5,734,000 -6,536,000 -30,770,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 225,000 227,000 223,000 804,000
Net Income/Loss -15,404,000 -5,734,000 -6,536,000 -30,770,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -15,404,000 -5,734,000 -6,536,000 -30,770,000
Net Income/Loss Available To Common Stockholders, Basic -15,404,000 -5,734,000 -6,536,000 -30,770,000
Operating Expenses 15,351,000 5,662,000 6,509,000 32,477,000
Operating Income/Loss -15,306,000 -5,617,000 -6,368,000 -30,304,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 45,000 45,000 141,000 2,173,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-08 2018-11-08 2019-03-15
Assets 104,462,000 88,016,000 69,381,000 44,120,000
Current Assets 103,229,000 86,821,000 68,189,000 42,944,000
Current Liabilities 13,843,000 10,946,000 14,865,000 10,476,000
Equity 85,931,000 66,672,000 44,081,000 23,620,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 85,931,000 66,672,000 44,081,000 23,620,000
Liabilities 18,531,000 21,344,000 25,300,000 20,500,000
Liabilities And Equity 104,462,000 88,016,000 69,381,000 44,120,000
Noncurrent Assets 1,233,000 1,195,000 1,192,000 1,176,000
Noncurrent Liabilities 4,688,000 10,398,000 10,435,000 10,024,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-08 2018-11-08 2019-03-15
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 75,610,000 -49,649,000 -19,344,000 -1,181,000
Net Cash Flow, Continuing 75,610,000 -49,649,000 -19,344,000 -1,181,000
Net Cash Flow From Financing Activities 79,018,000 2,741,000 0 81,779,000
Net Cash Flow From Financing Activities, Continuing 79,018,000 2,741,000 0 81,779,000
Net Cash Flow From Investing Activities 12,245,000 -32,821,000 375,000 -3,760,000
Net Cash Flow From Investing Activities, Continuing 12,245,000 -32,821,000 375,000 -3,760,000
Net Cash Flow From Operating Activities -15,653,000 -19,569,000 -19,719,000 -79,200,000
Net Cash Flow From Operating Activities, Continuing -15,653,000 -19,569,000 -19,719,000 -79,200,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-08 2018-11-08 2019-03-15
Comprehensive Income/Loss -16,607,000 -20,701,000 -23,872,000 -82,818,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -16,600,000 -20,699,000 -23,877,000 -82,818,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-08 2018-11-08 2019-03-15
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 82,848,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 82,848,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -16,607,000 -20,701,000 -23,872,000 -82,818,000
Income/Loss From Continuing Operations Before Tax -16,607,000 -20,701,000 -23,872,000 -82,818,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 161,000 186,000 220,000 791,000
Net Income/Loss -16,607,000 -20,701,000 -23,872,000 -82,818,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -16,607,000 -20,701,000 -23,872,000 -82,818,000
Net Income/Loss Available To Common Stockholders, Basic -16,607,000 -20,701,000 -23,872,000 -82,818,000
Operating Expenses 16,453,000 20,904,000 23,956,000 82,975,000
Operating Income/Loss -16,453,000 -20,904,000 -23,956,000 -82,945,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 30,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-11 2017-11-09 2018-03-16
Assets 81,958,000 68,415,000 54,875,000 40,493,000
Current Assets 80,484,000 67,002,000 53,480,000 39,201,000
Current Liabilities 7,186,000 7,136,000 11,695,000 13,519,000
Equity 67,163,000 54,326,000 36,895,000 21,415,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 67,163,000 54,326,000 36,895,000 21,415,000
Liabilities 14,795,000 14,089,000 17,980,000 19,078,000
Liabilities And Equity 81,958,000 68,415,000 54,875,000 40,493,000
Noncurrent Assets 1,474,000 1,413,000 1,395,000 1,292,000
Noncurrent Liabilities 7,609,000 6,953,000 6,285,000 5,559,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-11 2017-11-09 2018-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -11,835,000 -6,314,000 -386,000 -25,600,000
Net Cash Flow, Continuing -11,835,000 -6,314,000 -386,000 -25,600,000
Net Cash Flow From Financing Activities 5,133,000 159,000 1,000 5,362,000
Net Cash Flow From Financing Activities, Continuing 5,133,000 159,000 1,000 5,362,000
Net Cash Flow From Investing Activities -5,990,000 5,078,000 13,074,000 20,121,000
Net Cash Flow From Investing Activities, Continuing -5,990,000 5,078,000 13,074,000 20,121,000
Net Cash Flow From Operating Activities -10,978,000 -11,551,000 -13,461,000 -51,083,000
Net Cash Flow From Operating Activities, Continuing -10,978,000 -11,551,000 -13,461,000 -51,083,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-11 2017-11-09 2018-03-16
Comprehensive Income/Loss -10,373,000 -13,773,000 -18,336,000 -58,970,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -10,381,000 -13,775,000 -18,321,000 -58,970,000
Other Comprehensive Income/Loss 0 0 0 5,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-10 2017-08-11 2017-11-09 2018-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 13,903,000 18,491,000 59,320,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 10,261,000 13,768,000 18,348,000 58,753,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -10,373,000 -13,773,000 -18,336,000 -58,975,000
Income/Loss From Continuing Operations Before Tax -10,373,000 -13,773,000 -18,336,000 -58,975,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 156,000 162,000 168,000 653,000
Net Income/Loss -10,373,000 -13,773,000 -18,336,000 -58,975,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -10,373,000 -13,773,000 -18,336,000 -58,975,000
Net Income/Loss Available To Common Stockholders, Basic -10,373,000 -13,773,000 -18,336,000 -58,975,000
Operating Expenses 10,261,000 13,768,000 18,348,000 58,753,000
Operating Income/Loss -10,256,000 -13,638,000 -18,193,000 -58,408,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 5,000 130,000 155,000 345,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-12 2016-11-14 2017-03-16
Assets UNPUB 56,164,000 57,771,000 84,813,000
Current Assets UNPUB 56,033,000 57,654,000 84,317,000
Current Liabilities UNPUB 6,733,000 2,928,000 5,408,000
Equity UNPUB 45,896,000 46,938,000 71,659,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 45,896,000 46,938,000 71,659,000
Liabilities UNPUB 10,268,000 10,833,000 13,154,000
Liabilities And Equity UNPUB 56,164,000 57,771,000 84,813,000
Noncurrent Assets UNPUB 131,000 117,000 496,000
Noncurrent Liabilities UNPUB 3,535,000 7,905,000 7,746,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-12 2016-11-14 2017-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB -18,403,000 14,541,000
Net Cash Flow, Continuing UNPUB UNPUB -18,403,000 14,541,000
Net Cash Flow From Financing Activities UNPUB UNPUB 8,039,000 86,390,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 8,039,000 86,390,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -49,140,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -49,140,000
Net Cash Flow From Operating Activities UNPUB UNPUB -6,374,000 -22,709,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -6,374,000 -22,709,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-12 2016-11-14 2017-03-16
Comprehensive Income/Loss UNPUB -5,102,000 -5,645,000 -25,895,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -5,102,000 -5,650,000 -25,895,000
Other Comprehensive Income/Loss UNPUB 0 0 -13,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-12 2016-11-14 2017-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB 0 0 0
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB 5,183,000 5,311,000 25,718,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB -5,102,000 -5,645,000 -25,882,000
Income/Loss From Continuing Operations Before Tax UNPUB -5,102,000 -5,645,000 520,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB 44,000 39,000 287,000
Net Income/Loss UNPUB -5,102,000 -5,645,000 -25,882,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -5,102,000 -5,645,000 -25,882,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -5,102,000 -5,645,000 -25,882,000
Operating Expenses UNPUB 5,183,000 5,311,000 25,718,000
Operating Income/Loss UNPUB -5,178,000 -5,306,000 -25,198,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 5,000 5,000 520,000
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:CLSD240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:CLSD240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:CLSD240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:CLSD240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:CLSD240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:CLSD240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:CLSD240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:CLSD240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:CLSD240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:CLSD240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:CLSD240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:CLSD240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:CLSD240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:CLSD240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:CLSD240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:CLSD240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:CLSD240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:CLSD240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:CLSD240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:CLSD240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:CLSD240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:CLSD240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:CLSD240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:CLSD240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:CLSD240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:CLSD240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:CLSD240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:CLSD240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:CLSD240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:CLSD240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:CLSD240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:CLSD240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:CLSD240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:CLSD240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:CLSD231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:CLSD231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:CLSD231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:CLSD231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:CLSD231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:CLSD231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:CLSD231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:CLSD231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:CLSD231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:CLSD231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:CLSD231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:CLSD231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:CLSD231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:CLSD231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:CLSD231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:CLSD231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:CLSD231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:CLSD231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:CLSD230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:CLSD230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:CLSD230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:CLSD230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:CLSD230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:CLSD230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:CLSD230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:CLSD230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:CLSD230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:CLSD230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:CLSD230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:CLSD230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Calendar Calendar of Events
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 9:30 a.m. ET in New York, NY.
GlobeNewswire Inc. • 1w ago
Calendar Calendar of Events
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024
ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its first quarter 2024 financial results will be reported on Thursday, May 9, 2024 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
GlobeNewswire Inc. • 2w ago
Management Directors and Officers
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 3:00 p.m. ET.
GlobeNewswire Inc. • 1mo ago
Management Directors and Officers
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Industry Veteran with Extensive Experience in Retinal Disease Research and Strong Track Record in Advancing Programs Through Clinical Development Industry Veteran with Extensive Experience in Retinal Disease Research and Strong Track Record in Advancing Programs Through Clinical Development
GlobeNewswire Inc. • 2mo ago
Stocks Earnings Releases and Operating Results
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 -
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
ALPHARETTA, Ga., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its fourth quarter and full year 2023 financial results will be reported on Tuesday, March 12, 2024 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
GlobeNewswire Inc. • 2mo ago
Health Health
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
GlobeNewswire Inc. • 5mo ago
Calendar Calendar of Events
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference
ALPHARETTA, Ga., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, will participate in a fireside chat at the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at 8:35 a.m. ET in New York, NY.
GlobeNewswire Inc. • 6mo ago
Calendar Calendar of Events
Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting
Robust Safety Profile and Encouraging Efficacy Data Utilizing SCS Microinjector® Featured in Multiple Data Presentations Robust Safety Profile and Encouraging Efficacy Data Utilizing SCS Microinjector® Featured in Multiple Data Presentations
GlobeNewswire Inc. • 6mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT